Facebook Linkedin Twitter
Inside Precision Medicine Janssen Biotech to Use Adaptive’s clonoSEQ Assay in Darzalex Myeloma Trials

Drugs

Companies will use clonSEQ Assay for measuring minimal residual disease in multiple myeloma patients who have been treated with Darzalex. [iStock/©dmbaker]
Molecular Dx

Janssen Biotech to Use Adaptive’s clonoSEQ Assay in Darzalex Myeloma Trials

0
Source: © Photographee.eu/Fotolia
Molecular Dx

Thermo Fisher to Develop NGS-based CDx for Agios’ Cancer Candidate

0
Source: Getty Images
News & Features

New CRISPR Technique to Activate Silent Gene Clusters Could Yield New Drugs

0
Source: Myriad Genetics
Molecular Dx

Myriad to Develop CDx for BeiGene’s PARP Inhibitor BGB-290

0
Plasmacytoid variant of urothelial carcinoma
Molecular Dx

Loxo Oncology, Ventana in CDx Development Collaboration for Cancer Candidate Larotrectinib

0
Patrick Aloy
Informatics

In Silico Insights: Harnessing Bioinformatics to Find New Breast Cancer Drug Combinations

Diana Kwon
0
DNA sequence with colored letters on black background containing mutation
Molecular Dx

Strata Oncology to Offer Patient ID and Enrollment for Epizyme Trial of NHL Candidate

0
Prostate Cancer Slide
Molecular Dx

GenomeDx Tests, Database to Help Astellas Identify Patients for Prostate Cancer Drug Xtandi

0
Dementia disease and a loss of brain function and memories
Molecular Dx

Researchers Link Effect of Cancer Drug With Alzheimer’s-Protecting Mutation

0
Source: NIH
Molecular Dx

New Sequencing Technique for Cisplatin Damaged DNA Unveiled

0
1...626364Page 63 of 64

Related Content

Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.
Inside Precision Medicine